Search research articles
Contact Us
Filters
Showing results (141-150 of 466) with videos related to
Page
of 47
Sort By:
Blood
|
August 21, 2008
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sandrine Sander, Lars Bullinger, Kay Klapproth, et al.
Cancer Research
|
February 22, 2012
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells
Valentina Kovaleva, Rodrigo Mora, Yoon Jung Park, et al.
Hemasphere
|
February 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia
Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, et al.
Haematologica
|
April 16, 2016
Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling
Katharina Filarsky, Angela Garding, Natalia Becker, et al.
Blood
|
August 12, 2008
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up
Thorsten Zenz, Alexander Kröber, Katrin Scherer, et al.
Leukemia & Lymphoma
|
December 10, 2020
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib
Jacqueline C Barrientos, Peter Hillmen, Gilles Salles, et al.
Haematologica
|
March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
Marc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Haematologica
|
March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials
Valentin Goede, Paula Cramer, Raymonde Busch, et al.
Blood
|
October 24, 2002
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell
Tiemo Katzenberger, Andreas Lohr, Stephan Schwarz, et al.
Cancers
|
June 16, 2019
Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia
Lena Schulze-Edinghausen, Claudia Dürr, Selcen Öztürk, et al.
Page
of 47
Search research articles
Search
Showing results (141-150 of 466) with videos related to
Sort By:
Page
of 47
Blood
|
August 21, 2008
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sandrine Sander, Lars Bullinger, Kay Klapproth, et al.
Cancer Research
|
February 22, 2012
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells
Valentina Kovaleva, Rodrigo Mora, Yoon Jung Park, et al.
Hemasphere
|
February 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia
Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, et al.
Haematologica
|
April 16, 2016
Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling
Katharina Filarsky, Angela Garding, Natalia Becker, et al.
Blood
|
August 12, 2008
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up
Thorsten Zenz, Alexander Kröber, Katrin Scherer, et al.
Leukemia & Lymphoma
|
December 10, 2020
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib
Jacqueline C Barrientos, Peter Hillmen, Gilles Salles, et al.
Haematologica
|
March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
Marc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Haematologica
|
March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials
Valentin Goede, Paula Cramer, Raymonde Busch, et al.
Blood
|
October 24, 2002
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell
Tiemo Katzenberger, Andreas Lohr, Stephan Schwarz, et al.
Cancers
|
June 16, 2019
Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia
Lena Schulze-Edinghausen, Claudia Dürr, Selcen Öztürk, et al.
Page
of 47